These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31528136)

  • 1. Impella-Induced Incessant Ventricular Tachycardia.
    Kaki A; Subahi A; Shokr M; Ibrahim W; Yassin A; Hasan R; Alraies MC; Schreiber T
    Ochsner J; 2019; 19(3):248-251. PubMed ID: 31528136
    [No Abstract]   [Full Text] [Related]  

  • 2. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
    J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock.
    Haertel F; Lenk K; Fritzenwanger M; Pfeifer R; Franz M; Memisevic N; Otto S; Lauer B; Weingärtner O; Kretzschmar D; Dannberg G; Westphal J; Baez L; Bogoviku J; Schulze PC; Moebius-Winkler S
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach.
    Tschöpe C; Spillmann F; Potapov E; Faragli A; Rapis K; Nelki V; Post H; Schmidt G; Alogna A
    Front Cardiovasc Med; 2021; 8():563484. PubMed ID: 33681302
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock.
    Vora N; Chaudhary R; Upadhyay HV; Konat A; Zalavadia P; Padaniya A; Patel P; Patel N; Prajjwal P; Sharma K
    Cureus; 2023 Jan; 15(1):e33372. PubMed ID: 36751242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Impella Cardiac Power Device Used in Patient with Cardiogenic Shock due to Nonischemic Cardiomyopathy.
    Cena M; Karam F; Ramineni R; Khalife W; Barbagelata A
    Int J Angiol; 2016 Dec; 25(4):258-262. PubMed ID: 27867292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest.
    Vase H; Christensen S; Christiansen A; Therkelsen CJ; Christiansen EH; Eiskjær H; Poulsen SH
    Resuscitation; 2017 Mar; 112():70-74. PubMed ID: 27751862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience.
    Hritani AW; Wani AS; Olet S; Lauterbach CJ; Allaqaband SQ; Bajwa T; Jan MF
    J Invasive Cardiol; 2019 Sep; 31(9):E265-E270. PubMed ID: 31478893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
    Vetrovec GW; Anderson M; Schreiber T; Popma J; Lombardi W; Maini B; Moller JE; Schäfer A; Dixon SR; Hall S; Ohman EM; Mindrescu C; Moses J; O'Neill W
    Am Heart J; 2018 May; 199():115-121. PubMed ID: 29754648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support.
    Lü F; Eckman PM; Liao KK; Apostolidou I; John R; Chen T; Das GS; Francis GS; Lei H; Trohman RG; Benditt DG
    Int J Cardiol; 2013 Oct; 168(4):3859-65. PubMed ID: 23863501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Perioperative Care for Ventricular Tachycardia Ablation in High-Risk Patients Supported by Impella 5.5.
    Jaganathan N; Devarapalli M; Kumar V
    Cureus; 2024 Apr; 16(4):e58642. PubMed ID: 38770455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.